Last reviewed · How we verify
NCT05570487
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
trial testing Since the data were collected retrospectively, there were no interventions in the Records of Esophageal Cancer in 1,600 participants. Status unknown.
1 December 2022
Quick facts
| Lead sponsor | Yongtao Han |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,600 |
| Start date | 1 October 2022 |
| Primary completion | 1 December 2022 |
| Estimated completion | 1 October 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Since the data were collected retrospectively, there were no interventions
Conditions studied
- the Records of Esophageal Cancer — all drugs for the Records of Esophageal Cancer →
Sponsor
Yongtao Han — full company profile →
Who can join
Adults 18 to 90, any sex, with the Records of Esophageal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To clarify the effect of the number of lymph node dissection and the number of stations on survival
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study.
Li K, Leng X, He W, Du K, et al · · 2023 · cited 25× · PMID 37222685 · DOI 10.1097/js9.0000000000000436 -
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma in pT2 and pT3.
Li K, Leng X, Peng L. · · 2024 · cited 4× · PMID 38116658 · DOI 10.1097/js9.0000000000001023
Verify or expand the search:
- PubMed search for NCT05570487
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Since the data were collected retrospectively, there were no interventions
Trials testing the same drug.
- NCT05617352 — The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squam · completed
- NCT05604950 — Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years · completed
Other Yongtao Han trials
Trials by the same sponsor.
- NCT06169930 — Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy · completed
- NCT05617352 — The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squam · completed
- NCT05604664 — Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc · completed
- NCT07236320 — Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC · NA · completed
- NCT06775652 — Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05570487 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yongtao Han
- Last refreshed: 25 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05570487.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing